1-16023533-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004070.4(CLCNKA):​c.101-267A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.7 in 152,186 control chromosomes in the GnomAD database, including 37,614 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37614 hom., cov: 33)

Consequence

CLCNKA
NM_004070.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.180

Publications

6 publications found
Variant links:
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CLCNKA Gene-Disease associations (from GenCC):
  • Bartter disease type 4B
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-16023533-A-G is Benign according to our data. Variant chr1-16023533-A-G is described in ClinVar as [Benign]. Clinvar id is 1283626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.952 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKANM_004070.4 linkc.101-267A>G intron_variant Intron 2 of 19 ENST00000331433.5 NP_004061.3 P51800-1
CLCNKANM_001042704.2 linkc.101-267A>G intron_variant Intron 2 of 19 NP_001036169.1 P51800-3
CLCNKANM_001257139.2 linkc.101-267A>G intron_variant Intron 2 of 18 NP_001244068.1 P51800-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKAENST00000331433.5 linkc.101-267A>G intron_variant Intron 2 of 19 1 NM_004070.4 ENSP00000332771.4 P51800-1

Frequencies

GnomAD3 genomes
AF:
0.700
AC:
106400
AN:
152068
Hom.:
37589
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.741
Gnomad AMI
AF:
0.568
Gnomad AMR
AF:
0.643
Gnomad ASJ
AF:
0.600
Gnomad EAS
AF:
0.975
Gnomad SAS
AF:
0.640
Gnomad FIN
AF:
0.710
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.675
Gnomad OTH
AF:
0.713
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.700
AC:
106476
AN:
152186
Hom.:
37614
Cov.:
33
AF XY:
0.699
AC XY:
51966
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.741
AC:
30772
AN:
41524
American (AMR)
AF:
0.642
AC:
9826
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.600
AC:
2082
AN:
3470
East Asian (EAS)
AF:
0.974
AC:
5041
AN:
5174
South Asian (SAS)
AF:
0.639
AC:
3082
AN:
4824
European-Finnish (FIN)
AF:
0.710
AC:
7522
AN:
10594
Middle Eastern (MID)
AF:
0.704
AC:
207
AN:
294
European-Non Finnish (NFE)
AF:
0.675
AC:
45923
AN:
67988
Other (OTH)
AF:
0.712
AC:
1504
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1620
3240
4860
6480
8100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.695
Hom.:
4554
Bravo
AF:
0.697
Asia WGS
AF:
0.792
AC:
2752
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
6.0
DANN
Benign
0.62
PhyloP100
-0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2017583; hg19: chr1-16350028; API